Open AccessNiacin Lowers Serum Phosphate and Increases HDL Cholesterol in Dialysis Patients
Author(s) -
Daniela MuCombining Diaeresisller,
Heidrun Mehling,
BjoCombining Diaeresis Otto,
Regine Bergmann-Lips,
Friedrich C. Luft,
Jens Jordan,
Ralph Kettritz
Publication year - 2007
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.01470307
Subject(s) - medicine , niacin , tolerability , hyperphosphatemia , dialysis , cholesterol , adverse effect , pharmacology , kidney disease
Adverse effects complicate the use of drugs that are prescribed for phosphate control in dialysis patients. Alternative treatment options are needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom